期刊文献+

芒果苷原料药中杂质高芒果苷的含量测定 被引量:1

Determination of Impurity of Homomangiferin in Raw Medicine of Mangiferin by HPLC
下载PDF
导出
摘要 目的分析测定芒果苷原料药中高芒果苷的含量。方法采用C18柱(大连依利特分析仪器有限公司,Hypersil ODS 5μm,4.6mm×250mm),流动相为甲醇-0.1%磷酸(32:68),流速1ml/min,检测波长258nm。结果高芒果苷在0.0424-0.848μg范围内进样量与峰面积呈良好的线性关系(r=0.9999),平均回收率为97.8%,RSD=2.2%(n=6)。结论该方法简便,灵敏,重复性好,可作为芒果苷原料药中高芒果苷的含量测定方法。 Objective To determine Homomangiferin in raw medicine of Mangiferin by HPLC. Methods Homomangiferin was separated on Hypersil ODS 5μm column (4.6 mmID × 250mm) with a mobile phase of methanol -0. 1% phosphoric acid solution (32:68 ) and detected at a wavelength of 258 nm. Results The calibration curve was linear in the range of 0.042 4 - 0. 848 μg (r = 0.999 9). The average recovery rate was 97.8% and RSD = 2.2% (n = 6). Conclusion The method is simple, sensitive and precise. It can be used for the determination of Homomangiferin in raw medicine of Mangifierin.
机构地区 广西中医学院
出处 《时珍国医国药》 CAS CSCD 北大核心 2008年第6期1295-1296,共2页 Lishizhen Medicine and Materia Medica Research
基金 国家科技部重大项目资助课题(No.2004BA901A09) 广西科技厅科技创新能力与条件建设项目(No.桂科能0630006-5A)
关键词 高芒果苷 芒果苷原料药 高效液相色谱 Raw medicine of Mangiferin The content of Homomangiferin HPLC
  • 相关文献

参考文献2

二级参考文献21

  • 1彭志刚,罗军,夏凌辉,陈燕,宋善俊.芒果甙诱导慢性髓系白血病K562细胞凋亡[J].中国实验血液学杂志,2004,12(5):590-594. 被引量:18
  • 2彭志刚,罗军,夏凌辉,宋善俊,陈燕.芒果甙对白血病K562细胞增殖抑制作用的研究[J].广西医科大学学报,2004,21(2):168-170. 被引量:19
  • 3Sanchez GM,Re L,Giuliani A,et al.Protective effects of Mangifera indica L.extrat,mangiferin and selected antioxidants against TPA-induced biomolecules oxidation and peritoneal macrophage activation in mice[J].Pharmacol Res,2000,42(6):565-573
  • 4Dairy I,Reeja S,Siddharth,et al.Evaluation of antibacterial activity of mangifera indica on anaerobic dental microglora based on in vivo studies[J].Indian J Pathol Microbiol,2002,45(3):307-310
  • 5Yoosook C,Bunyapraphatsara N,Boonyakiat Y,et al.Anti-herpes simplex virus activity of crude water extvacts of Thai medicinal plants[J].Phytomedicine,2000,6(6):411-419
  • 6Yoshikawa M,Ninomiya K,Shimoda H,et al.Hepatoprotective and antioxidative properties of Salacia reticulata:preventive effects of phenolic constituents on ccl4-induced liver injury in mice[J].Biol Pharm Bull,2002,25 (1):72-76
  • 7Muruganandan S,Gupta S,Kataria M,et al.Mangiferin protects the streptozotocin-induced oxidative damage to cardiac and renal tissues in rats[J].Toxicology,2002,176(3):165-173
  • 8Ichiki H,Miura T,Kubo M,et al.New antidiabetic compounds,mangiferin and its glucoside[J].Biol Pharm Bull,1998,21(12):1389-1390
  • 9Miura T,I wamoto N,Kato M,et al.The suppressive effect of mangfferin with exercise on blood lipids in type 2 diabetes[J].Biol Pharm Bull,2001,24(9):1091-1092
  • 10Yoshikawa M,Shimoda H,Nishida N,et al.Salacia reticulata and its polyphenlic constituent with lipase inhibitory and lipolytic activities have mild antiobesity effects in rats[J].J Nutr,2002,132(7):1819-1824

共引文献96

同被引文献17

  • 1肖衍宇,宋赟梅,陈志鹏,平其能.水飞蓟素前体脂质体的制备和大鼠药代动力学的研究[J].药学学报,2005,40(8):758-763. 被引量:27
  • 2张婷婷,徐文,胡生亮,何仲贵.水飞蓟宾在不同介质中平衡溶解度和表观油水分配系数的测定[J].中国药学杂志,2006,41(20):1569-1571. 被引量:49
  • 3左巨波,尚京川.中药磷脂复合物的研究进展[J].中国药房,2007,18(27):2149-2151. 被引量:17
  • 4MURUGANANDAN S,SRINIVASAN K,GUPTA S.Effect of mangiferin on hyperglycemia and atherogenicity in streptozotocin diabetic rats[J].J Ethnopharmacol,2005,97(3):497-501.
  • 5PARDO-ANDREU GL,DELGADO R,NU'EZ-SELLS AJ,et al.Mangifera indica L.extract(Viming) inhibits 2-deoxyribose damage induce by Fe(Ⅲ) plus ascorbate[J].Phytother Res,2006,20(2):120-124.
  • 6RAJENDRAN P,EKAMBARAM G,MAGESH V,et al.Chemo preventive efficacy of mangiferin against benzo(a) pyrene induced lung carcinogenesis in experimental animals[J].Environ Toxicol Pharmacol,2008,26(3):278-282.
  • 7DANDAN H,CHENG JC,CONG Z,et al.Determination of mangiferin in rat plasma by liquid-liquid extraction with UPLC-MS/MS[J].J Pharmaceut Biomed,2010,51(1):260-263.
  • 8LI CL,DENG YJ.Oil-based formulations for oral delivery of insulin[J].J Pharm Pharmacol,2004,56(9):1101-1107.
  • 9WANG S,SUN M,PING Q.Enhancing effect of Labrafac Lipophile WL 1349 on oral bioavailability of hydroxysafflor yellow A in rats[J].Int J Pharm,2008,358(1):198-204.
  • 10XIONG J,GUO J,HUANG L,et al.The use of lipid-based formulations to increase the oral bioavailability of Panax notoginseng saponins following a single oral gavage to rats[J].Drug Dev Ind Pharm,2008,34(1):65-72.

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部